News & Events about Seelos Therapeutics Inc.
Seelos Therapeutics to Participate in the 12th Annual LifeSci Partners Corporate Access Event Seelos Therapeutics to Participate in the 12th Annual LifeSci Partners Corporate Access Event PR Newswire NEW YORK, Dec. 22, 2022 NEW YORK, Dec. 22, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq...
Seelos Therapeutics to Hold a Research and Development Update Conference Call and Webcast on December 15, 2022 Seelos Therapeutics to Hold a Research and Development Update Conference Call and Webcast on December 15, 2022 PR Newswire NEW YORK, Nov. 23, 2022 NEW YORK, Nov. 23, 2022 /PRNewswire...
Seelos Therapeutics to Participate in the Guggenheim 4th Annual Immunology and Neurology Day Seelos Therapeutics to Participate in the Guggenheim 4th Annual Immunology and Neurology Day PR Newswire NEW YORK, Nov. 7, 2022 NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq...
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer's Disease Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer's Disease PR Newswire NEW YORK, Oct. 5, 2022 FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Oct. 5, 2022...
Seelos Therapeutics to Collaborate with the Healey & AMG Center for ALS in an Expanded Access Program Funded by a Grant from the National Institute of Neurological Disorders and Stroke under the Accelerating Access to Critical Therapies for ALS Act (ACT for ALS) Seelos Therapeutics to...